296 related articles for article (PubMed ID: 20473774)
21. Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.
Tovmasyan A; Sheng H; Weitner T; Arulpragasam A; Lu M; Warner DS; Vujaskovic Z; Spasojevic I; Batinic-Haberle I
Med Princ Pract; 2013; 22(2):103-30. PubMed ID: 23075911
[TBL] [Abstract][Full Text] [Related]
22. SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself.
DeFreitas-Silva G; Rebouças JS; Spasojević I; Benov L; Idemori YM; Batinić-Haberle I
Arch Biochem Biophys; 2008 Sep; 477(1):105-12. PubMed ID: 18477465
[TBL] [Abstract][Full Text] [Related]
23. Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: voltammetric and chronocoulometric study of protolytic and redox equilibria.
Weitner T; Kos I; Mandić Z; Batinić-Haberle I; Biruš M
Dalton Trans; 2013 Oct; 42(41):14757-65. PubMed ID: 23933742
[TBL] [Abstract][Full Text] [Related]
24. A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.
Batinic-Haberle I; Rajic Z; Benov L
Anticancer Agents Med Chem; 2011 May; 11(4):329-40. PubMed ID: 21355843
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.
Sheng H; Spasojevic I; Tse HM; Jung JY; Hong J; Zhang Z; Piganelli JD; Batinic-Haberle I; Warner DS
J Pharmacol Exp Ther; 2011 Sep; 338(3):906-16. PubMed ID: 21652782
[TBL] [Abstract][Full Text] [Related]
26. Manganese-porphyrin reactions with lipids and lipoproteins.
Bloodsworth A; O'Donnell VB; Batinic-Haberle I; Chumley PH; Hurt JB; Day BJ; Crow JP; Freeman BA
Free Radic Biol Med; 2000 Apr; 28(7):1017-29. PubMed ID: 10832063
[TBL] [Abstract][Full Text] [Related]
27. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.
Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I
Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553
[TBL] [Abstract][Full Text] [Related]
28. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.
Tovmasyan A; Maia CG; Weitner T; Carballal S; Sampaio RS; Lieb D; Ghazaryan R; Ivanovic-Burmazovic I; Ferrer-Sueta G; Radi R; Reboucas JS; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Sep; 86():308-21. PubMed ID: 26026699
[TBL] [Abstract][Full Text] [Related]
30. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
31. An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.
Batinic-Haberle I; Tovmasyan A; Spasojevic I
Redox Biol; 2015 Aug; 5():43-65. PubMed ID: 25827425
[TBL] [Abstract][Full Text] [Related]
32. New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme.
Batinić-Haberle I; Spasojević I; Stevens RD; Bondurant B; Okado-Matsumoto A; Fridovich I; Vujasković Z; Dewhirst MW
Dalton Trans; 2006 Jan; (4):617-24. PubMed ID: 16402149
[TBL] [Abstract][Full Text] [Related]
33. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.
Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D
Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro antioxidant properties of manganese(III) beta-octabromo-meso-tetrakis(4-carboxyphenyl)porphyrin.
Kachadourian R; Flaherty MM; Crumbliss AL; Patel M; Day BJ
J Inorg Biochem; 2003 Jul; 95(4):240-8. PubMed ID: 12818794
[TBL] [Abstract][Full Text] [Related]
35. Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.
Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
J Endourol; 2012 Nov; 26(11):1420-4. PubMed ID: 22783812
[TBL] [Abstract][Full Text] [Related]
36. Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: potentiometric, spectrophotometric and spectroelectrochemical study of protolytic and redox equilibria.
Weitner T; Budimir A; Kos I; Batinić-Haberle I; Biruš M
Dalton Trans; 2010 Dec; 39(48):11568-76. PubMed ID: 21052598
[TBL] [Abstract][Full Text] [Related]
37. Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid.
Trostchansky A; Ferrer-Sueta G; Batthyány C; Botti H; Batinić-Haberle I; Radi R; Rubbo H
Free Radic Biol Med; 2003 Nov; 35(10):1293-300. PubMed ID: 14607528
[TBL] [Abstract][Full Text] [Related]
38. H
Batinic-Haberle I; Tovmasyan A; Huang Z; Duan W; Du L; Siamakpour-Reihani S; Cao Z; Sheng H; Spasojevic I; Alvarez Secord A
Oxid Med Cell Longev; 2021; 2021():6653790. PubMed ID: 33815656
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP.
Shin SW; Choi C; Lee GH; Son A; Kim SH; Park HC; Batinic-Haberle I; Park W
Antioxid Redox Signal; 2017 Nov; 27(14):1067-1082. PubMed ID: 28358581
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the compounds commonly known as superoxide dismutase and catalase mimics in cellular models.
Vincent A; Thauvin M; Quévrain E; Mathieu E; Layani S; Seksik P; Batinic-Haberle I; Vriz S; Policar C; Delsuc N
J Inorg Biochem; 2021 Jun; 219():111431. PubMed ID: 33798828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
